Use of the OLFM4 protein in colorectal cancer diagnosis - Archive ouverte HAL Access content directly
Patents Year : 2012

Use of the OLFM4 protein in colorectal cancer diagnosis

(1) , (1) , ,
1
Benjamin Barré
  • Function : Author
Erik Gamelin
  • Function : Author

Abstract

The present invention provides a method for diagnosing KRAS mutations in colorectal cancers by measuring the level of OLFM4. In another aspect, the present invention relates a method of predicting the responds to a chemotherapeutic agent of a subject suffering from a colorectal cancer: according to the present invention, the by determining the OLFM4 levels. According to the present invention, the response can be predicted by determining the OLFM4 levels. This result in turn permits the design or the adaptation of a treatment of the said subject with the said chemotherapeutic agent.

Not file

Dates and versions

hal-03389745 , version 1 (21-10-2021)

Identifiers

  • HAL Id : hal-03389745 , version 1
  • OKINA : ua9240

Cite

Catherine Guette, Olivier Coqueret, Benjamin Barré, Erik Gamelin. Use of the OLFM4 protein in colorectal cancer diagnosis. France, Patent n° : Non spécifié. 2012. ⟨hal-03389745⟩
7 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More